alfapump was very effective in control of ascites, virtually eliminating the need for large volume paracentesis (LVP) long term Key POSEIDON investigators report alfapump is safe and effective tool ...
Sequana Medical NV received premarket approval from the U.S. FDA for its Alfapump system to treat recurrent or refractory ascites due to liver cirrhosis. Data from the Poseidon pivotal study showed ...
Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis The Company will be hosting a further webcast with key opinion ...